Overexpression of serine/threonine‑protein kinase-1 in pancreatic cancer tissue: Serine/threonine-protein kinase-1 knockdown increases the chemosensitivity of pancreatic cancer cells

Wang,Qingguang; Xu,Dong; Han,Chao; Tu,Min; Du,Qing; Zhang,Jingjing; Zhu,Yi; Xu,Lijian

doi:10.3892/mmr.2015.3434

Overexpression of serine/threonine‑protein kinase-1 in pancreatic cancer tissue: Serine/threonine-protein kinase-1 knockdown increases the chemosensitivity of pancreatic cancer cells

Authors:
- Qingguang Wang
- Dong Xu
- Chao Han
- Min Tu
- Qing Du
- Jingjing Zhang
- Yi Zhu
- Lijian Xu
View Affiliations

Affiliations: Department of General Surgery, Zoucheng People's Hospital, Jining, Shandong 273500, P.R. China, Department of General Surgery, Gaochun People's Hospital, Nanjing, Jiangsu 211300, P.R. China, Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210011, P.R. China, Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
Published online on: March 5, 2015 https://doi.org/10.3892/mmr.2015.3434
Pages: 475-481

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Serine/threonine‑protein kinase‑1 (SMG‑1) belongs to the phosphatidylinositol 3‑kinase‑related kinase family. Altered expression of SMG‑1 contributes to human carcinogenesis and cancer progression. The present study detected the expression levels of SMG‑1 in normal and cancerous pancreatic tissues and then assessed the effects of SMG‑1‑knockdown in pancreatic cancer cell lines in vitro. A pancreatic cancer tissue array and pancreatic cancer cell lines were used to detect the expression levels of SMG‑1 and a lentivirus expressing either SMG‑1 or negative control short hairpin (sh)RNA were used to knock down the expression of SMG‑1 in the pancreatic cancer cell lines. Western blot, cell proliferation, Cell Counting kit‑8, Transwell tumor cell migration and invasion assays, and flow cytometric analysis of cell apoptosis with or without gemcitabine or cisplatin treatment were performed to assess the tumor cells. The protein expression of SMG‑1 was higher in the pancreatic cancer tissues and cells compared with the normal tissues. sh‑SMG‑1 lentivirus infection significantly suppressed the expression of SMG‑1 in the pancreatic cancer cell lines, resulting in the inhibition of tumor cell proliferation and increased chemosensitivity to treatment with gemcitabine and cisplatin. However, SMG‑1 knockdown had no effect on pancreatic cancer cell migration or invasion capacities. The protein expression of SMG‑1 was increased in the pancreatic cancer tissues and was associated with an advanced tumor stage. Knock down of the expression of SMG‑1 inhibited tumor cell proliferation and induced the chemosensitivity of pancreatic cancer cells in vitro.

View Figures

View References

1	Yadav D and Lowenfels AB: The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 144:1252–1261. 2013. View Article : Google Scholar : PubMed/NCBI
2	Ghadirian P, Lynch HT and Krewski D: Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev. 27:87–93. 2003. View Article : Google Scholar : PubMed/NCBI
3	Han H and Von Hoff DD: SnapShot: pancreatic cancer. Cancer Cell. 23:424. 2013. View Article : Google Scholar : PubMed/NCBI
4	Yamashita A, Ohnishi T, Kashima I, Taya Y and Ohno S: Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay. Genes Dev. 15:2215–2228. 2001. View Article : Google Scholar : PubMed/NCBI
5	Denning G, Jamieson L, Maquat LE, Thompson EA and Fields AP: Cloning of a novel phosphatidylinositol kinase-related kinase: characterization of the human SMG-1 RNA surveillance protein. J Biol Chem. 276:22709–22714. 2001. View Article : Google Scholar : PubMed/NCBI
6	Gehen SC, Staversky RJ, Bambara RA, Keng PC and O’Reilly MA: hSMG-1 and ATM sequentially and independently regulate the G1 checkpoint during oxidative stress. Oncogene. 27:4065–4074. 2008. View Article : Google Scholar : PubMed/NCBI
7	Brumbaugh KM, Otterness DM, Geisen C, et al: The mRNA surveillance protein hSMG-1 functions in genotoxic stress response pathways in mammalian cells. Mol Cell. 14:585–598. 2004. View Article : Google Scholar : PubMed/NCBI
8	Greenman C, Stephens P, Smith R, et al: Patterns of somatic mutation in human cancer genomes. Nature. 446:153–158. 2007. View Article : Google Scholar : PubMed/NCBI
9	Uhlen M, Oksvold P, Fagerberg L, et al: Towards a knowledge-based Human Protein Atlas. Nat Biotechnol. 28:1248–1250. 2010. View Article : Google Scholar : PubMed/NCBI
10	Gubanova E, Issaeva N, Gokturk C, Djureinovic T and Helleday T: SMG-1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways. Cell Cycle. 12:3770–3780. 2013. View Article : Google Scholar : PubMed/NCBI
11	Erker L, Schubert R, Yakushiji H, et al: Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor. Hum Mol Genet. 14:1699–1708. 2005. View Article : Google Scholar : PubMed/NCBI
12	Gubanova E, Brown B, Ivanov SV, et al: Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival. Clin Cancer Res. 18:1257–1267. 2012. View Article : Google Scholar : PubMed/NCBI
13	Oliveira V, Romanow WJ, Geisen C, et al: A protective role for the human SMG-1 kinase against tumor necrosis factor-α-induced apoptosis. J Biol Chem. 283:13174–13184. 2008. View Article : Google Scholar : PubMed/NCBI
14	Tiedemann RE, Zhu YX, Schmidt J, et al: Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6. Blood. 115:1594–1604. 2010. View Article : Google Scholar :
15	Neben K, Schnittger S, Brors B, et al: Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype. Oncogene. 24:1580–1588. 2005. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
17	Chen RQ, Yang QK, Chen YL, et al: Kinome siRNA screen identifies SMG-1 as a negative regulator of hypoxia-inducible factor-1α in hypoxia. J Biol Chem. 284:16752–16758. 2009. View Article : Google Scholar : PubMed/NCBI
18	Noensie EN and Dietz HC: A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition. Nat Biotechnol. 19:434–439. 2001. View Article : Google Scholar : PubMed/NCBI
19	Perrin-Vidoz L, Sinilnikova OM, Stoppa-Lyonnet D, Lenoir GM and Mazoyer S: The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons. Hum Mol Genet. 11:2805–2814. 2002. View Article : Google Scholar : PubMed/NCBI
20	González-Estévez C, Felix DA, Smith MD, et al: SMG-1 and mTORC1 act antagonistically to regulate response to injury and growth in planarians. PLoS Genet. 8:e10026192012. View Article : Google Scholar : PubMed/NCBI
21	Roberts TL, Ho U, Luff J, et al: Smg1 haploinsufficiency predisposes to tumor formation and inflammation. Proc Natl Acad Sci USA. 110:E285–294. 2013. View Article : Google Scholar : PubMed/NCBI
22	Masse I, Molin L, Mouchiroud L, et al: A novel role for the SMG-1 kinase in lifespan and oxidative stress resistance in Caenorhabditis elegans. PLoS One. 3:e33542008. View Article : Google Scholar : PubMed/NCBI
23	Abraham RT: PI 3-kinase related kinases: ‘big’ players in stress-induced signaling pathways. DNA Repair (Amst). 3:883–887. 2004. View Article : Google Scholar
24	Brummelkamp TR, Bernards R and Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:550–553. 2002. View Article : Google Scholar : PubMed/NCBI
25	Philip PA: Targeted therapies for pancreatic cancer. Gastrointest Cancer Res. 2:S16–S19. 2008.
26	Xia QS, Li YZ, Li HY, et al: Effect of inhibiting the expression of hSMG-1 on chemosensitivity of human non-small cell lung cancer H1299 cells. Zhonghua Yi Xue Za Zhi. 91:554–559. 2011.In Chinese. PubMed/NCBI